Hyderabad, India-based Aurobindo Pharma said that it will expand its facility at its East Windsor, New Jersey, campus to set up a manufacturing facility for injectable products. Aurobindo's U.S., business chief, Bob Cunard, said in an earnings briefing that "the company has the bandwidth to add manufacturing in the United...